Akèy › Enfeksyon Viris Epstein-Barr › Maryland
Etid klinik pou Enfeksyon Viris Epstein-Barr nan Maryland
6 etid pou Enfeksyon Viris Epstein-Barr ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT03258567Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 29 · Tout sèks · Mizajou Sep 8, 2026 · NCT06908096Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Aug 25, 2026 · NCT05389423A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 1 a 120 · Tout sèks · Mizajou Jul 28, 2026 · NCT00032513EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Johns Hopkins, Baltimore
Ap rekriteFaz 2
1 Month – 79 Years · Tout sèks · Mizajou Aug 8, 2025 · NCT03266653Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.